Efficacy of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after gynecological cancer surgery: A systematic review and meta-analysis.

Summary: For women recovering from gynecological cancer surgery, preventing blood clots is crucial. Traditionally, this involves daily injections of a blood thinner called LMWH (like enoxaparin). A new analysis of five studies involving over 1,400 patients compared these injections to Direct Oral Anticoagulants (DOACs)—blood thinners taken as a pill. The results are encouraging: the pills were just as effective at preventing clots and did not increase the risk of major bleeding. Even better, patients taking the pills experienced significantly less "minor" bleeding compared to those taking the shots. This suggests that oral medication is a safe, effective, and potentially more convenient alternative to injections for post-surgery recovery.